Patient
SITE001-0263
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE001 (USA) (Dr. Reyes)
consented 2026-07-10
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-09-16
Grade 1 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-03-12 (study day 55); relationship: not assessed
moderate
assessed
2026-09-07
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-03-03 (study day 46); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.